STOCK TITAN

Morgan Stanley (MS) April 8, 2026 addendum supersedes earlier Series F prospectuses

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

Morgan Stanley files a prospectus addendum and accompanying prospectus supplement dated April 8, 2026 for Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F. The addendum clarifies that the April 8, 2026 prospectus and supplement supersede earlier versions for market-making transactions.

Positive

  • None.

Negative

  • None.
Registration Statement No. 333-293641 cover prospectus addendum
Prospectus / Supplement Date April 8, 2026 accompanying prospectus and prospectus supplement
Series Series F Global Medium-Term Notes, Global Units, Global Warrants
prospectus supplement regulatory
"the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
market-making transactions market
"used in connection with market-making transactions of notes, units or warrants"
Global Medium-Term Notes financial
"GLOBAL MEDIUM-TERM NOTES, SERIES F GLOBAL UNITS, SERIES F GLOBAL WARRANTS, SERIES F"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does Morgan Stanley's April 8, 2026 prospectus addendum for MS cover?

It updates and supersedes earlier prospectuses and supplements. The addendum states the April 8, 2026 prospectus and prospectus supplement replace earlier dated versions for Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F used in market-making transactions.

Will Morgan Stanley receive proceeds from the market-making transactions in this addendum (MS)?

The addendum describes market-making use of the prospectus materials. It does not state proceeds treatment or issuance of new securities; the language focuses on which prospectus supplement and prospectus supersede earlier versions for market-making transactions.

Are the Series F notes, units or warrants insured or bank obligations (MS)?

No, they are not insured or bank obligations. The addendum explicitly states the offered notes, units or warrants are not deposits or savings accounts, not FDIC insured, and are not obligations of or guaranteed by any bank or governmental agency.

What should investors read when offered Series F securities under MS filings?

Read the specific pricing or prospectus supplement with the April 8, 2026 prospectus. The addendum instructs readers to read the specific terms in the pricing or prospectus supplement together with the April 8, 2026 prospectus supplement and prospectus, which supersede earlier versions.

 

Filed Pursuant to Rule 424(b)(3)
Registration Statement No. 333-293641

 

Prospectus Addendum to 

the Prospectus Supplement dated April 8, 2026 and
the accompanying Prospectus dated April 8, 2026

 

 

GLOBAL MEDIUM-TERM NOTES, SERIES F
GLOBAL UNITS, SERIES F
GLOBAL WARRANTS, SERIES F

 

Morgan Stanley & Co. LLC will, and other affiliates of Morgan Stanley may, use this prospectus addendum, the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F and/or the accompanying prospectus dated April 8, 2026 in connection with market-making transactions of notes, units or warrants that were originally issued under a similar prospectus supplement for Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F with a date earlier than April 8, 2026, and/or a similar prospectus with a date earlier than April 8, 2026. We refer below to such earlier prospectus supplement as the “earlier prospectus supplement” and such earlier prospectus as the “earlier prospectus.”

 

When this prospectus addendum, the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F and the accompanying prospectus dated April 8, 2026 are used in connection with a market-making transaction, you should note that the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F supersedes the earlier prospectus supplement, and the accompanying prospectus dated April 8, 2026 supersedes the earlier prospectus. When you read the prospectus supplement or pricing supplement with the specific terms of the offered notes, units or warrants, please note that all references in it to the earlier prospectus supplement should instead refer to the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F, and all references in it to the earlier prospectus should instead refer to the accompanying prospectus dated April 8, 2026.

 

You should read the terms of the accompanying prospectus supplement or pricing supplement, which describes the specific terms of the offered notes, units or warrants, together with the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F and/or the accompanying prospectus dated April 8, 2026.

 

The offered notes, units or warrants are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

 

 

MORGAN STANLEY

 

April 8, 2026